HuGE Literature Finder
Records
1
-
17
| The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD. Clinical and translational gastroenterology 2021 Sep 12 (9): e00400. Vilar-Gomez Eduardo, Pirola Carlos J, Sookoian Silvia, Wilson Laura A, Liang Tiebing, Chalasani Na |
| Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease. Hepatology international 2021 Jun . Paternostro Rafael, Staufer Katharina, Traussnigg Stefan, Stättermayer Albert-Friedrich, Halilbasic Emina, Keritam Omar, Meyer Elias L, Stift Judith, Wrba Fritz, Sipos Bence, Canbay Ali, Schlattjan Martin, Aigner Elmar, Datz Christian, Stickel Felix, Schafmayer Clemens, Hampe Jochen, Buch Stephan, Prager Gerhard, Munda Petra, Mandorfer Mattias, Ferenci Peter, Trauner Micha |
| The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography. Alimentary pharmacology & therapeutics 2021 May . Ajmera Veeral, Liu Amy, Bettencourt Ricki, Dhar Debanjan, Richards Lisa, Loomba Roh |
| Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease. Journal of clinical and translational hepatology 2021 Apr 9 (2): 194-202. Liu Wen-Yue, Eslam Mohammed, Zheng Kenneth I, Ma Hong-Lei, Rios Rafael S, Lv Min-Zhi, Li Gang, Tang Liang-Jie, Zhu Pei-Wu, Wang Xiao-Dong, Byrne Christopher D, Targher Giovanni, George Jacob, Zheng Ming-H |
| The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease. Nutrition, metabolism, and cardiovascular diseases : NMCD 2021 Feb . Sun Dan-Qin, Wang Ting-Yao, Zheng Kenneth I, Zhang Hao-Yang, Wang Xiao-Dong, Targher Giovanni, Byrne Christopher D, Chen Yong-Ping, Yuan Wei-Jie, Jin Yan, Zheng Ming-H |
| Insights into genetic variants associated with NASH-fibrosis from metabolite profiling. Human molecular genetics 2020 Jul . Mann Jake P, Pietzner Maik, Wittemans Laura B, Rolfe Emmanuela De Lucia, Kerrison Nicola D, Imamura Fumiaki, Forouhi Nita G, Fauman Eric, Allison Michael E, Griffin Jules L, Koulman Albert, Wareham Nicholas J, Langenberg Claud |
| Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 2020 Apr . Seko Yuya, Yamaguchi Kanji, Tochiki Nozomi, Yano Kota, Takahashi Aya, Okishio Shinya, Kataoka Seita, Okuda Keiichiroh, Umemura Atsushi, Moriguchi Michihisa, Tanaka Saiyu, Mori Kojiroh, Okanoue Takeshi, Itoh Yoshi |
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort.
Journal of hepatology 2020 Apr . Anstee Quentin M, Darlay Rebecca, Cockell Simon, Meroni Marica, Govaere Olivier, Tiniakos Dina, Burt Alastair D, Bedossa Pierre, Palmer Jeremy, Liu Yang-Lin, Aithal Guruprasad P, Allison Michael, Yki-Järvinen Hannele, Vacca Michele, Dufour Jean-Francois, Invernizzi Pietro, Prati Daniele, Ekstedt Mattias, Kechagias Stergios, Francque Sven, Petta Salvatore, Bugianesi Elisabetta, Clement Karine, Ratziu Vlad, Schattenberg Jörn M, Valenti Luca, Day Christopher P, Cordell Heather J, Daly Ann K, |
| Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients. International journal of molecular sciences 2020 Apr 21 (9): . Enomoto Hirayuki, Aizawa Nobuhiro, Hasegawa Kunihiro, Ikeda Naoto, Sakai Yoshiyuki, Yoh Kazunori, Takata Ryo, Yuri Yukihisa, Kishino Kyohei, Shimono Yoshihiro, Ishii Noriko, Takashima Tomoyuki, Nishimura Takashi, Nishikawa Hiroki, Iwata Yoshinori, Iijima Hiroko, Nishiguchi Shuh |
| Development and Validation of a Scoring System, Based on Genetic and Clinical Factors, to Determine Risk of Steatohepatitis in Asian Patients with Nonalcoholic Fatty Liver Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Feb . Koo Bo Kyung, Joo Sae Kyung, Kim Donghee, Lee Seonhwa, Bae Jeong Mo, Park Jeong Hwan, Kim Jung Ho, Chang Mee Soo, Kim W |
| Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension. Liver international : official journal of the International Association for the Study of the Liver 2020 Feb 40 (2): 393-404. Scheiner Bernhard, Stättermayer Albert F, Schwabl Philipp, Bucsics Theresa, Paternostro Rafael, Bauer David, Simbrunner Benedikt, Schmidt Ralf, Marculescu Rodrig, Ferlitsch Arnulf, Peck-Radosavljevic Markus, Pinter Mathias, Trauner Michael, Reiberger Thomas, Ferenci Peter, Mandorfer Matti |
| Association of HSD17B13 rs72613567:TA with non-alcoholic fatty liver disease in Hispanics/Latinos. Liver international : official journal of the International Association for the Study of the Liver 2020 Jan . Kallwitz Eric, Tayo Bamidele O, Kuniholm Mark H, Daviglus Martha, Zeng Donglin, Isasi Carmen R, Cotler Scott |
| Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms. Diabetes & metabolism journal 2019 Oct 43 (5): 700-710. Bellan Mattia, Colletta Cosimo, Barbaglia Matteo Nazzareno, Salmi Livia, Clerici Roberto, Mallela Venkata Ramana, Castello Luigi Mario, Saglietti Giuseppe, Carnevale Schianca Gian Piero, Minisini Rosalba, Pirisi Mar |
| High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant. Hepatology (Baltimore, Md.) 2019 Jun . Gellert-Kristensen Helene, Nordestgaard Børge Grønne, Tybjaerg-Hansen Anne, Stender Stef |
| 17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease. Hepatology (Baltimore, Md.) 2019 Apr 69 (4): 1504-1519. Ma Yanling, Belyaeva Olga V, Brown Philip M, Fujita Koji, Valles Katherine, Karki Suman, de Boer Ynto S, Koh Christopher, Chen Yanhua, Du Xiaomeng, Handelman Samuel K, Chen Vincent, Speliotes Elizabeth K, Nestlerode Cara, Thomas Emmanuel, Kleiner David E, Zmuda Joseph M, Sanyal Arun J, , Kedishvili Natalia Y, Liang T Jake, Rotman Yar |
| Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease. Journal of lipid research 2019 Jan 60 (1): 176-185. Pirola Carlos J, Garaycoechea Martin, Flichman Diego, Arrese Marco, San Martino Julio, Gazzi Carla, Castaño Gustavo O, Sookoian Silv |
| Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits. Endocrine journal 2014 61 (7): 683-9. Kitamoto Aya, Kitamoto Takuya, Nakamura Takahiro, Ogawa Yuji, Yoneda Masato, Hyogo Hideyuki, Ochi Hidenori, Mizusawa Seiho, Ueno Takato, Nakao Kazuwa, Sekine Akihiro, Chayama Kazuaki, Nakajima Atsushi, Hotta Kiku |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: